Prostate Cancer - Results from #23120

Canadian prostate brachytherapy in 2012 - Abstract June 21, 2013

Clinical significance of suboptimal hormonal levels in men with prostate cancer treated with LHRH agonists - Abstract June 21, 2013

Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system? - Abstract June 21, 2013

Metastatic prostate cancer with malignant ascites: A case report and literature review - Abstract June 21, 2013

A current perspective on the use of genomics in the diagnosis and treatment of prostate cancer, an interview with Stephen J. Freedland, MD June 21, 2013

Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy, by Stephen J. Freedland, MD June 21, 2013

AUA 2013 - Poster: Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy June 21, 2013

Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy - Abstract June 20, 2013

Long-term outcome for prostate cancer using pseudo pulse-dosed rate brachytherapy, external beam radiotherapy, and hormones - Abstract June 20, 2013

A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression - Abstract June 20, 2013

Impact of experience and technical changes on acute urinary and rectal morbidity in low-dose prostate brachytherapy using loose seeds real-time implantation - Abstract June 20, 2013

Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: Oncologic outcomes and morbidity in 1002 patients - Abstract June 20, 2013

Breast and prostate cancer survivors in a diabetic cohort: Results from the Living With Diabetes study - Abstract June 20, 2013

Technology diffusion and diagnostic testing for prostate cancer - Abstract June 20, 2013

Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate (TURP) and correlation with clinical and treatment parameters - Abstract June 20, 2013

Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer - Abstract June 19, 2013

Use of a clinical assistant to screen patients with genitourinary cancer to encourage entry into clinical trials and use of supportive medication: A pilot project at a Canadian cancer center - Abstract June 19, 2013

Castration-resistant prostate cancer: AUA Guideline - Abstract June 19, 2013

Defining high-risk prostate cancer - Abstract June 19, 2013

Results of hormone therapy as first-line treatment for high-risk prostate cancer - Abstract June 19, 2013

Page 1157 of 1447